Tanabe Pharma America Email Format
Pharmaceutical ManufacturingNew Jersey, United States201-500 Employees
Mitsubishi Tanabe Pharma America, Inc. is a pharmaceutical manufacturing company based in Jersey City, New Jersey, United States. It operates as a wholly owned subsidiary of Tanabe Pharma Corporation and was launched in 2016 to develop and advance its pipeline and to commercialize approved pharmaceutical products in North America. The organization employs between 201 and 500 people. Its research activities include programs such as MT-4561 for advanced solid tumors and ND0612 for Parkinson's disease, with involvement in industry conferences and poster presentations. In December 2024, MTPC announced a strategic research collaboration with Dewpoint Therapeutics, and the subsidiary has continued to participate in related scientific initiatives through 2025.